TRPV1 Activity and Substance P Release Are Required for Corneal Cold Nociception
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Substance P: Transmitter O. Nociception (Minireview)
ENDOCRINE REGULATIONS, Vol. 34,195201, 2000 195 SUBSTANCE P: TRANSMITTER O NOCICEPTION (MINIREVIEW) M. ZUBRZYCKA1, A. JANECKA2 1Department of Physiology and 2Department of General Chemistry, Institute of Physiology and Biochemistry, Medical University of Lodz, Lindleya 3, 90-131 Lodz, Poland E-mail: [email protected] Substance P plays the role of a neurotransmitter immunoreactive fibers has also been detected in lam- and neuromodulator in the central and peripheral ina V of the dorsal horn (LJUNGDAHL et al. 1978), lam- nervous system. The presence of substance P in de- ina X surrounding the central canal (LAMOTTE and myelinated sensory fibres, as well as in the small SHAPIRO 1991), the nucleus dorsalis, interomediolat- and medium-sized neurons of spinal dorsal horn sub- eral cell column, and the ventral horn (PIORO et stantia gelatinosa gives a structural basis for the al.1984). Electric stimulation of the dorsal root, or hypothesis that SP plays an important role of peripheral nerve endings, causes a substantial release a mediator in the processing of nociceptive informa- of SP within the substantia gelatinosa of spinal dor- tion. In this paper recent advances on the effect of sal horns (OTSUKA and KANISHI 1976). SP on conduction and modulation of nociceptive In the dorsal regions of the spinal dorsal horn, impulsation are reviewed. The studies concerning the besides SP also large quantities of gamma-aminobu- role of SP in the prevertebral ganglia and spinal dor- tyric acid (GABA) are present, but reduction of sal horns has been presented, including the distribu- GABA levels has no effect on the SP content, and tion of SP in the spinal cord, as well as its pre- and similarly, reduction of SP levels does not cause any postsynaptic actions on excitatory and inhibitory decrease of GABA concentration in this region of postsynaptic potentials (EPSP and IPSP) and the ef- the spinal cord (TAKAHASHI and OTSUKA 1975). -
Chapter Four – TRPA1 Channels: Chemical and Temperature Sensitivity
CHAPTER FOUR TRPA1 Channels: Chemical and Temperature Sensitivity Willem J. Laursen1,2, Sviatoslav N. Bagriantsev1,* and Elena O. Gracheva1,2,* 1Department of Cellular and Molecular Physiology, Yale University School of Medicine, New Haven, CT, USA 2Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT, USA *Corresponding author: E-mail: [email protected], [email protected] Contents 1. Introduction 90 2. Activation and Regulation of TRPA1 by Chemical Compounds 91 2.1 Chemical activation of TRPA1 by covalent modification 91 2.2 Noncovalent activation of TRPA1 97 2.3 Receptor-operated activation of TRPA1 99 3. Temperature Sensitivity of TRPA1 101 3.1 TRPA1 in mammals 101 3.2 TRPA1 in insects and worms 103 3.3 TRPA1 in fish, birds, reptiles, and amphibians 103 3.4 TRPA1: Molecular mechanism of temperature sensitivity 104 Acknowledgments 107 References 107 Abstract Transient receptor potential ankyrin 1 (TRPA1) is a polymodal excitatory ion channel found in sensory neurons of different organisms, ranging from worms to humans. Since its discovery as an uncharacterized transmembrane protein in human fibroblasts, TRPA1 has become one of the most intensively studied ion channels. Its function has been linked to regulation of heat and cold perception, mechanosensitivity, hearing, inflam- mation, pain, circadian rhythms, chemoreception, and other processes. Some of these proposed functions remain controversial, while others have gathered considerable experimental support. A truly polymodal ion channel, TRPA1 is activated by various stimuli, including electrophilic chemicals, oxygen, temperature, and mechanical force, yet the molecular mechanism of TRPA1 gating remains obscure. In this review, we discuss recent advances in the understanding of TRPA1 physiology, pharmacology, and molecular function. -
Cannabinoid Receptor and Inflammation
Cannabinoid Receptor and Inflammation Newman Osafo1, Oduro Yeboah1, Aaron Antwi1, and George Ainooson1 1Kwame Nkrumah University of Science and Technology September 11, 2020 Abstract The eventual discovery of endogenous cannabinoid receptors CB1 and CB2 and their endogenous ligands has generated interest with regards to finally understanding the endocannabinoid system. Its role in the normal physiology of the body and its implication in pathological states such as cardiovascular diseases, neoplasm, depression and pain have been subjects of scientific interest. In this review the authors focus on the endogenous cannabinoid pathway, the critical role of cannabinoid receptors in signaling and mediation of neurodegeneration and other inflammatory responses as well as its potential as a drug target in the amelioration of some inflammatory conditions. Though the exact role of the endocannabinoid system is not fully understood, the evidence found leans heavily towards a great potential in exploiting both its central and peripheral pathways in disease management. Cannabinoid therapy has already shown great promise in several preclinical and clinical trials. 1.0 Introduction Ethnopharmacological studies have shown the use of Cannabis sativa in traditional medicine for over a thousand years, with its widespread use promoted by its psychotropic effects (McCoy, 2016; Turcotte et al., 2016). The discovery of a receptor within human body, that is selectively activated by cannabinoids suggested the presence of at least one endogenous ligand for this receptor. This is confirmed by the discovery of two endogenously synthesized lipid mediators, 2-arachidonoyl-glycerol and arachidonoylethanolamide, which function as high-affinity ligands for a subfamily of cannabinoid receptors ubiquitously distributed in the central nervous system, known as the CB1 receptors (Turcotte et al., 2016). -
Recognition and Alleviation of Distress in Laboratory Animals
http://www.nap.edu/catalog/11931.html We ship printed books within 1 business day; personal PDFs are available immediately. Recognition and Alleviation of Distress in Laboratory Animals Committee on Recognition and Alleviation of Distress in Laboratory Animals, National Research Council ISBN: 0-309-10818-7, 132 pages, 6 x 9, (2008) This PDF is available from the National Academies Press at: http://www.nap.edu/catalog/11931.html Visit the National Academies Press online, the authoritative source for all books from the National Academy of Sciences, the National Academy of Engineering, the Institute of Medicine, and the National Research Council: x Download hundreds of free books in PDF x Read thousands of books online for free x Explore our innovative research tools – try the “Research Dashboard” now! x Sign up to be notified when new books are published x Purchase printed books and selected PDF files Thank you for downloading this PDF. If you have comments, questions or just want more information about the books published by the National Academies Press, you may contact our customer service department toll- free at 888-624-8373, visit us online, or send an email to [email protected]. This book plus thousands more are available at http://www.nap.edu. Copyright © National Academy of Sciences. All rights reserved. Unless otherwise indicated, all materials in this PDF File are copyrighted by the National Academy of Sciences. Distribution, posting, or copying is strictly prohibited without written permission of the National Academies Press. Request reprint permission for this book. Recognition and Alleviation of Distress in Laboratory Animals http://www.nap.edu/catalog/11931.html Recognition and Alleviation of Distress in Laboratory Animals Committee on Recognition and Alleviation of Distress in Laboratory Animals Institute for Laboratory Animal Research Division on Earth and Life Studies THE NATIONAL ACADEMIES PRESS Washington, D.C. -
N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation Via Nonhematopoietic TRPV1
N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via Nonhematopoietic TRPV1 This information is current as Samira K. Lawton, Fengyun Xu, Alphonso Tran, Erika of October 1, 2021. Wong, Arun Prakash, Mark Schumacher, Judith Hellman and Kevin Wilhelmsen J Immunol 2017; 199:1465-1475; Prepublished online 12 July 2017; doi: 10.4049/jimmunol.1602151 http://www.jimmunol.org/content/199/4/1465 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2017/07/12/jimmunol.160215 Material 1.DCSupplemental http://www.jimmunol.org/ References This article cites 69 articles, 11 of which you can access for free at: http://www.jimmunol.org/content/199/4/1465.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on October 1, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Author Choice Freely available online through The Journal of Immunology Author Choice option Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2017 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via Nonhematopoietic TRPV1 Samira K. -
Nociceptors – Characteristics?
Nociceptors – characteristics? • ? • ? • ? • ? • ? • ? Nociceptors - true/false No – pain is an experience NonociceptornotNoNo – –all nociceptors– TRPV1 nociceptorsC fibers somata is areexpressed may alsoin have • Nociceptors are pain fibers typically associated with Typically yes, but therelowsensorynociceptorsinhave manyisor ahigh efferentsemantic gangliadifferent thresholds and functions mayproblemnot cells, all befor • All C fibers are nociceptors nociceptoractivationsmallnociceptorsincluding or large non-neuronalactivation are in Cdiameter fibers tissue • Nociceptors have small diameter somata • All nociceptors express TRPV1 channels • Nociceptors have high thresholds for response • Nociceptors have only afferent (sensory) functions • Nociceptors encode stimuli into the noxious range Nociceptors – outline Why are nociceptors important? What’s a nociceptor? Nociceptor properties – somata, axons, content, etc. Nociceptors in skin, muscle, joints & viscera Mechanically-insensitive nociceptors (sleeping or silent) Microneurography Heterogeneity Why are nociceptors important? • Pain relief when remove afferent drive • Afferent is more accessible • With peripherally restricted intervention, can avoid many of the most deleterious side effects Widespread hyperalgesia in irritable bowel syndrome is dynamically maintained by tonic visceral impulse input …. Price DD, Craggs JG, Zhou Q, Verne GN, et al. Neuroimage 47:995-1001, 2009 IBS IBS rectal rectal placebo lidocaine rectal lidocaine Time (min) Importantly, areas of somatic referral were -
Monitoring the Nociception Level Intraoperatively - an Initial Experiences
Research Article J Anest & Inten Care Med Volume 7 Issue 2 - July 2018 Copyright © All rights are reserved by Pether Jildenstål DOI: 10.19080/JAICM.2018.07.555709 Monitoring the Nociception Level Intraoperatively - An Initial Experiences Pether Jildenstål1,2*, Katarina Hallén2, Katarina Almskog3, Johan Sand3 and Margareta Warren Stomberg1 1Institute of Health and Care Sciences, University of Gothenburg, Sweden 2Department of Anesthesiology, Surgery and Intensive Care, Sahlgrenska University Hospital, Sweden 3Department of Anesthesiology and Intensive care, Queen Silvia Children’s Hospital, Sweden Submission: July 5, 2018; Published: July 25, 2018 *Corresponding author: Pether Jildenstål, Institute of Health and Care Sciences, University of Gothenburg, Sweden, Email: Abstract Background: when vasopressors are used as well. There is an increasing interest during general anesthesia to understand how optimal anesthesia changes by Estimating pain stimuli in the anesthetized patient can be difficult when based solely upon physiological parameters, especially its exact use in routine clinical practice is still not well proven. The aim of this study was to identify relationships between PMD 200 monitoring, Nociceptionthe level of noxious Level (NOL-index) stimulation. and Objectively, monitored noxious known stimulation physiological measurement signs as well monitoring as outcomes techniques during general are gaining anesthesia. interest. Although currently, Method: during the intraoperativeEight patients period. between the ages of 43 and 83 years old and scheduled for major head and neck surgery under general anesthesia were observed in this study. NoL index sensor was placed on one of the patient’s fingers before anesthesia was induced, and values were extracted Results: of the bladder, and with surgical skin incision. -
Pharmacology for PAIN: Prescribing Controlled Substances
The Impact of Pain Pharmacology for PAIN: The National Center for Health Prescribing Controlled Statistics estimates that 32.8% of the U.S. population has persistent pain ~94 million U.S. residents have episodic or Substances persistent pain (1 in every 5 adults) Judith A. Kaufmann, Dr PH, FNP-BC Treatment for chronic pain rarely Robert Morris University results in complete relief and full functional recovery Of patients diagnosed with chronic pain and treated by a PCP, 64 percent report persistent pain two years after treatment initiation US Statistics: The Alarming Impact of Pain Facts Pain ranks low on medical tx priority Americans constitute 4.6% of world’s only 15% of primary care physicians report that they "enjoy" treating patients with chronic pain population-but consume ~ 80% of world’s Dahl et al., and Redford (2002) found that patients opioid supply said they fear dying in pain more than they fear death Americans consume 99% of world supply of hydrocodone Pain over the past 10 years has been designated the 5th vital sign Between 1999 and 2006, the number of people >age 12 using illicit prescription Pain is 3rd leading cause of absence pain relievers doubled from 2.6 to 5.2 from work million 2006 National Survey on Drug Use and Health (NSDUH) Are we the Pushers? Can we be found guilty? Since 1999, opioid analgesic poisonings on 55.7% of users obtained drugs from a death certificates increased 91% friend or relative who had been prescribed the drugs from 1 provider During same period, fatal heroin and cocaine poisonings increased 12.4% and 22.8% 19.1% of users obtained their drug directly respectively from 1 provider In 2008, 36,450 opioid deaths were 1.6% reported doctor shopping reported 3.9% reported purchasing drugs from a CDC, 2011 dealer Male:female ratio = 1.5:1 but death rate for females ia 20x higher than males 1 Is opioid abuse a recent Classifications of Pain phenomenon? Acute V. -
Reduced Inflammatory Hyperalgesia with Preservation of Acute Thermal Nociception in Mice Lacking Cgmp-Dependent Protein Kinase I
Reduced inflammatory hyperalgesia with preservation of acute thermal nociception in mice lacking cGMP-dependent protein kinase I Irmgard Tegeder*†, Domenico Del Turco‡, Achim Schmidtko*, Matthias Sausbier§, Robert Feil¶, Franz Hofmann¶, Thomas Deller‡, Peter Ruth§, and Gerd Geisslinger* *pharmazentrum frankfurt and ‡Institut fu¨r Klinische Neuroanatomie, Klinikum der Johann Wolfgang Goethe-Universita¨t, 60590 Frankfurt am Main, Germany; §Pharmakologie und Toxikologie, Pharmazeutisches Institut, Universita¨t Tu¨ bingen, 72076 Tu¨bingen, Germany; and ¶Institut fu¨r Pharmakologie und Toxikologie der Technischen Universita¨t, 80802 Munich, Germany Edited by Joseph A. Beavo, University of Washington School of Medicine, Seattle, WA, and approved December 18, 2003 (received for review July 1, 2003) cGMP-dependent protein kinase I (PKG-I) has been suggested to tion on the PNAS web site.) Hence, the exact role of PKG-I in contribute to the facilitation of nociceptive transmission in the nociception remains elusive. spinal cord presumably by acting as a downstream target of nitric In the present study we used PKG-IϪ/Ϫ mice to clearly assess oxide. However, PKG-I activators caused conflicting effects on the role of PKG-I in nociception. Because these mice have a nociceptive behavior. In the present study we used PKG-I؊/؊ mice defective regulation of smooth muscle contraction with vascular to further assess the role of PKG-I in nociception. PKG-I deficiency and intestinal dysfunctions (17, 18), the overall constitution of Ϫ Ϫ was associated with reduced nociceptive behavior in the formalin homozygous PKG-I / mice deteriorates between 5 and 6 weeks assay and zymosan-induced paw inflammation. However, acute of age (17). -
Ion Channels of Nociception
International Journal of Molecular Sciences Editorial Ion Channels of Nociception Rashid Giniatullin A.I. Virtanen Institute, University of Eastern Finland, 70211 Kuopio, Finland; Rashid.Giniatullin@uef.fi; Tel.: +358-403553665 Received: 13 May 2020; Accepted: 15 May 2020; Published: 18 May 2020 Abstract: The special issue “Ion Channels of Nociception” contains 13 articles published by 73 authors from different countries united by the main focusing on the peripheral mechanisms of pain. The content covers the mechanisms of neuropathic, inflammatory, and dental pain as well as pain in migraine and diabetes, nociceptive roles of P2X3, ASIC, Piezo and TRP channels, pain control through GPCRs and pharmacological agents and non-pharmacological treatment with electroacupuncture. Keywords: pain; nociception; sensory neurons; ion channels; P2X3; TRPV1; TRPA1; ASIC; Piezo channels; migraine; tooth pain Sensation of pain is one of the fundamental attributes of most species, including humans. Physiological (acute) pain protects our physical and mental health from harmful stimuli, whereas chronic and pathological pain are debilitating and contribute to the disease state. Despite active studies for decades, molecular mechanisms of pain—especially of pathological pain—remain largely unaddressed, as evidenced by the growing number of patients with chronic forms of pain. There are, however, some very promising advances emerging. A new field of pain treatment via neuromodulation is quickly growing, as well as novel mechanistic explanations unleashing the efficiency of traditional techniques of Chinese medicine. New molecular actors with important roles in pain mechanisms are being characterized, such as the mechanosensitive Piezo ion channels [1]. Pain signals are detected by specialized sensory neurons, emitting nerve impulses encoding pain in response to noxious stimuli. -
Headache and Musculoskeletal Pain in School Children Are Associated with Uncorrected Vision Problems and Need for Glasses
www.nature.com/scientificreports OPEN Headache and musculoskeletal pain in school children are associated with uncorrected vision problems and need for glasses: a case–control study Hanne‑Mari Schiøtz Thorud*, Rakel Aurjord & Helle K. Falkenberg Musculoskeletal pain and headache are leading causes of years lived with disability, and an escalating problem in school children. Children spend increasingly more time reading and using digital screens, and increased near tasks intensify the workload on the precise coordination of the visual and head‑ stabilizing systems. Even minor vision problems can provoke headache and neck‑ and shoulder (pericranial) pain. This study investigated the association between headaches, pericranial tenderness, vision problems, and the need for glasses in children. An eye and physical examination was performed in twenty 10–15 year old children presenting to the school health nurse with headache and pericranial pain (pain group), and twenty age‑and‑gender matched classmates (control group). The results showed that twice as many children in the pain group had uncorrected vision and needed glasses. Most children were hyperopic, and glasses were recommended mainly for near work. Headache and pericranial tenderness were signifcantly correlated to reduced binocular vision, reduced distance vision, and the need for new glasses. That uncorrected vision problems are related to upper body musculoskeletal symptoms and headache, indicate that all children with these symptoms should have a full eye examination to promote health -
A Surgical Opinion on Hyperalgesia/Nociception
Send Orders of Reprints at [email protected] Current Immunology Reviews, 2012, 8, 275-286 275 A Surgical Opinion on Hyperalgesia/Nociception, Inflammatory/Neurogenic Pain and Anti-inflammatory Responses and Drug Interventions Revisited: Current Breakthroughs and Views John J. Haddad* Cellular and Molecular Physiology and Immunology Signaling Research Group, Biomedical Laboratory and Clinical Sciences Division, Department of Medical Laboratory Technology, Faculty of Health Sciences, Beirut Arab University, Beirut, Lebanon Abstract: All sensory modalities are essentially important, but pain serves a protective function and is indispensable for survival, and, technically, pain is considered one of the most common symptoms of injuries and related diseases. Inflammatory cells and inflammatory mediators are crucially involved in the propensity, genesis, persistence and severity of pain, commonly known as nociception or hyperalgesia, following trauma, infection, or nerve injury. When it pins down to the essential understanding of pain/hyperalgesia pathways and their intricate interactions with myriad probabilities of milieu of inflammatory cytokines and related molecules, the amicable concept of specificity and complexity remains a major dilemma. Various hyperalgesic models have been established to investigate this intricate relationship between pain perception and inflammatory responses. Illness-induced hyperalgesia, for instance, is one of the most common aspects of pain related-inflammation and therapeutic approach to this pain should aim at interfering with various mediators of the inflammatory reactions, including neuropeptides, eicosanoids and cytokines. In this surgical synopsis, a trajectory of neurochemical events and cascades are delineated and unraveled in terms of the connection that has ostensibly evolved for hyperalgesia-inflammatory responses. The unprecedented intricacy of pain-inflammatory relationship and putative pathways bears surmountable clinical and physiological relevance.